Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Receptor-activity-modifying proteins (RAMPs) are a family of single transmembrane domain proteins shown to be important for the transport and ligand specificity of the calcitonin gene-related peptide (CGRP) receptor. In this report, we describe the analysis of pharmacological properties of the human calcitonin receptor (hCTR) coexpressed with different RAMPs with the use of the Xenopus laevis melanophore expression system. We show that coexpression of RAMP3 with human calcitonin receptor changed the relative potency of hCTR to human calcitonin (hCAL) and rat amylin. RAMP1 and RAMP2, in contrast, had little effect on the change of hCTR potency to hCAL or rat amylin. When coexpressed with RAMP3, hCTR reversed the relative potency by a 3.5-fold loss in sensitivity to hCAL and a 19-fold increase in sensitivity to rat amylin. AC66, an inverse agonist, produced apparent simple competitive antagonism of hCAL and rat amylin, as indicated by linear Schild regressions. The potency of AC66 was changed in the blockade of rat amylin but not hCAL responses with RAMP3 coexpression. The mean pK(B) for AC66 to hCAL was 9.4 +/- 0.3 without RAMP3 and 9.45 +/- 0.07 with RAMP3. For the antagonism of AC66 to rat amylin, the pK(B) was 9.25 +/- 0.15 without RAMP3 and 8.2 +/- 0.35 with RAMP3. The finding suggests that RAMP3 might modify the active states of calcitonin receptor in such a way as to create a new receptor phenotype that is "amylin-like." Irrespective of the physiological association of t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, RAMPs were found to interact and modulate the pharmacology of CTR (11,37,156).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [11]
Citations
Cites
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O., & SCHILD, H. O. (1959) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1959.tb00928.x · Cited by 3,938
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Self-citationDifferential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
Morphine Activates Opioid Receptors without Causing Their Rapid Internalization
Keith, D. E., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Kang, L., Evans, C. J., & von Zastrow, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19021 · Cited by 552
Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510
Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Self-citationExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
Karne, S., Jayawickreme, C. K., & Lerner, M. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46743-3 · Cited by 365
A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor
Aiyar, N., Rand, K., Elshourbagy, N. A., Zeng, Z., Adamou, J. E., Bergsma, D. J., & Li, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11325 · Cited by 320
Robb, S., Cheek, T. R., Hannan, F. L., Hall, L. M., Midgley, J. M., & Evans, P. D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06385.x · Cited by 248
Research works printed but not linked: 4
- Davis, L. G., Kuehl, M. W., & Battey, J. F. (1994). Basic Methods in Molecular Biology, 2nd ed. (pp. 84–89). Norwalk, CT: Appleton & Lange.
- Kenakin, T. P. (1997). Pharmacologic Analyses of Drug Receptor Interaction, 3rd ed. (pp. 223–229). New York: Lippincott-Wilkins.
- Snedecor, G. W., & Cochrane, W. G. (1966). Statistical Methods (pp. 432–436). Ames, IA: Iowa State University Press.
- Watson, 1995, The pharmacology of amylin receptors in the rat nucleus accumbens, FASEB J, 9, A668
Cited by
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
Self-citationPoyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804
Self-citationKenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
Self-citationThe Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
KENAKIN, T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0438rev · Cited by 408
Self-citation
Metadata
- Authors
- Armour, S. L., Foord, S., Kenakin, T., & Chen, W.-J.
- Corresponding author
- Chen, Wen-Ji
- ORCID
- Kenakin, Terry
- Venue
- Journal of Pharmacological and Toxicological Methods
- Publisher
- Elsevier BV
- Published
- 1999-12
- Volume
- 42
- Issue
- 4
- Pages
- 217-224
- ISSN
- 1056-8719 (ISSN-L)
- OpenAlex
- W1988441237
- Semantic Scholar
- f0e66a3256e1178b85baadbb0b8d71c75a9c059b
- Cited by
- 96
- References
- 33
- Citations by year
- 2026: 5 · 2025: 3 · 2023: 1 · 2022: 5 · 2021: 3 · 2020: 7 · 2019: 6 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 2 · 2014: 4 · 2013: 1 · 2012: 1
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Pharmacological and Toxicological Methods (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- receptor activity-modifying proteins, RAMP3, RAMP1, RAMP2, calcitonin, amylin, inverse agonists, competitive antagonism, receptor co-expression, ligand specificity
- MeSH terms
- Amyloid, Animals, Anti-Ulcer Agents, Calcitonin, Humans, Membrane Proteins, Xenopus, Signal Transduction, Receptors, Calcitonin, Intracellular Signaling Peptides and Proteins, Rats, Islet Amyloid Polypeptide, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 1, Receptor Activity-Modifying Protein 2, Receptor Activity-Modifying Protein 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor. https://app.cochat.ai/papers/10.1016/s1056-8719(00)00074-5
- The paper
- Armour, S. L., Foord, S., Kenakin, T., & Chen, W.-J. (1999). Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor. Journal of Pharmacological and Toxicological Methods. https://doi.org/10.1016/s1056-8719(00)00074-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.